Serial intervals in SARS-CoV-2 B.1.617.2 variant cases - The Lancet

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01697-4/fulltext#supplementaryMaterial


Enviado desde mi iPhone

SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance | bioRxiv

https://www.biorxiv.org/content/10.1101/2021.07.28.454085v1


Enviado desde mi iPhone

People with Past COVID-19 Benefit from Immunization

https://www.jwatch.org/na53802/2021/07/08/people-with-past-covid-19-benefit-immunization?query=etoc_jwgenmed&jwd=000010738038&jspc=IM

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2108891?query=recirc_mostViewed_railB_article

REACT-1 round 13 final report: exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021

https://spiral.imperial.ac.uk/bitstream/10044/1/90800/2/react1_r13_final_preprint_final.pdf

LAS MISTERIOSAS MUTACIONES DELTA

https://espanol.medscape.com/verarticulo/5907442_print

El papel de la atención primaria en la pandemia COVID-19: Una mirada hacia Europa - ScienceDirect

https://www.sciencedirect.com/science/article/pii/S0212656721001682